Anti-Human EGFR Recombinant Antibody(Cetuximab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human EGFR Recombinant Antibody(Cetuximab)

Anti-Human EGFR Recombinant Antibody(Cetuximab)

产品编号

YR1089

别名

科研级 Cetuximab ( 西妥昔单抗 ), Anti-EGFR Recombinant Antibody, Research Grade Cetuximab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Cetuximab ( 西妥昔单抗 ), Anti-EGFR Recombinant Antibody, Research Grade Cetuximab
Catalog Number	YR1089
Molecular Name	Cetuximab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion that is distributed under the trade name Erbitux in the U.S. and Canada by the drug company Eli Lilly and Co.
CAS Number	205923-56-4
Application	IF, IP, Neut, FuncS, ELISA, FCM
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Molecular Weight	145.78 kDa
Target	EGFR[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0